Sanuwave Health (SNWV) Stock Price, News & Analysis

Company Overview

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

Key Stats

• Today's Range: $41.51 to $44.94
• 50-Day Range: $29.95 to $45.00
• 52-Week Range: $5.21 to $46.58
• Volume: 58,099 shs
• Average Volume: 48,845 shs
• Market Capitalization: $379.99 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $55.00
• Consensus Rating: Buy

SNWV Stock Analysis - Frequently Asked Questions

How have SNWV shares performed this year?

Sanuwave Health's stock was trading at $37.61 at the start of the year. Since then, SNWV shares have increased by 17.9% and is now trading at $44.34.

How were Sanuwave Health's earnings last quarter?

Sanuwave Health Inc. (NASDAQ:SNWV) issued its quarterly earnings data on Friday, August, 8th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.09) by $0.10. The firm earned $10.16 million during the quarter, compared to the consensus estimate of $10.14 million.
Read the conference call transcript.

Who are Sanuwave Health's major shareholders?

Top institutional shareholders of Sanuwave Health include Opaleye Management Inc. (11.44%), AWM Investment Company Inc. (5.71%), Geode Capital Management LLC (1.84%) and Stonebridge Wealth Management LLC (0.60%). Insiders that own company stock include Peter Stegagno and Iulian Cioanta.
View institutional ownership trends.

How do I buy shares of Sanuwave Health?

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/08/2025
• Today: 8/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SNWV
• Previous Symbol: NASDAQ:SNWV
• CIK: 1417663
• Web: N/A
• Phone: (770) 419-7525
• Fax: 770-419-8634
• Employees: 40
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Sanuwave Health: $55.00
• High Price Target: $55.00
• Low Price Target: $55.00
• Potential Upside/Downside: +25.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($8.25)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$31.37 million
• Net Margins: -97.03%
• Pretax Margin: -96.96%
• Return on Equity: N/A
• Return on Assets: -135.15%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.43
• Quick Ratio: 0.31

Sales & Book Value

• Annual Sales: $39.19 million
• Price / Sales: 9.58
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.72) per share
• Price / Book: -25.47

Miscellaneous

• Outstanding Shares: 8,568,000
• Free Float: 7,291,000
• Market Cap: $375.28 million
• Optionable: N/A
• Beta: 1.29